Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-12 Heerma Peter CHIEF COMMERCIAL OFFICER Sale 10b5-1 −2,568 $23.53 $60K 125,066
2025-02-12 Inrig Jula CHIEF MEDICAL OFFICER Sale −2,568 $23.53 $60K 89,602
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +10,000 $16.23 $162K 73,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −10,000 $25.00 $250K 63,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +10,000 $17.44 $174K 73,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −10,000 $25.00 $250K 63,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +10,000 $17.96 $180K 73,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −10,000 $25.00 $250K 63,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise 10b5-1 +15,000 $15.46 $232K 78,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −15,000 $25.00 $375K 63,654
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −9,244 $25.00 $231K 54,410
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −10,000 0
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −10,000 0
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −10,000 0
2025-02-11 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −15,000 0
2025-02-11 Heerma Peter CHIEF COMMERCIAL OFFICER Sale 10b5-1 −3,074 $25.00 $77K 127,634
2025-02-11 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −11,375 $24.04 $273K 419,173
2025-02-10 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Option exercise 10b5-1 +8,000 103,719
2025-02-10 ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D Option exercise · Performance-based restricted stock units 10b5-1 −8,000 0
2025-02-10 REED ELIZABETH E SVP, GC & CORPORATE SECRETARY Option exercise 10b5-1 +8,000 97,482

Page 19 of 51 · 1,020 trades